Phospholipid biosynthesis, dihydroceramide desaturase fatty acid desaturase
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 15 |
NetGPI | no | yes: 0, no: 15 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 16 |
GO:0110165 | cellular anatomical entity | 1 | 16 |
Related structures:
AlphaFold database: A4I2A2
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 16 |
GO:0006643 | membrane lipid metabolic process | 4 | 14 |
GO:0006665 | sphingolipid metabolic process | 4 | 14 |
GO:0006807 | nitrogen compound metabolic process | 2 | 14 |
GO:0008152 | metabolic process | 1 | 16 |
GO:0008610 | lipid biosynthetic process | 4 | 14 |
GO:0009058 | biosynthetic process | 2 | 14 |
GO:0009987 | cellular process | 1 | 14 |
GO:0030148 | sphingolipid biosynthetic process | 5 | 14 |
GO:0044237 | cellular metabolic process | 2 | 14 |
GO:0044238 | primary metabolic process | 2 | 16 |
GO:0044249 | cellular biosynthetic process | 3 | 14 |
GO:0044255 | cellular lipid metabolic process | 3 | 14 |
GO:0046467 | membrane lipid biosynthetic process | 4 | 14 |
GO:0071704 | organic substance metabolic process | 2 | 16 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 14 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 14 |
GO:1901576 | organic substance biosynthetic process | 3 | 14 |
GO:0006672 | ceramide metabolic process | 4 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0043603 | amide metabolic process | 3 | 2 |
GO:0043604 | amide biosynthetic process | 4 | 2 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 2 |
GO:0046513 | ceramide biosynthetic process | 5 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 14 |
GO:0016491 | oxidoreductase activity | 2 | 14 |
GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 3 | 14 |
GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water | 4 | 14 |
GO:0042284 | sphingolipid delta-4 desaturase activity | 5 | 14 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 137 | 141 | PF00656 | 0.279 |
CLV_PCSK_SKI1_1 | 158 | 162 | PF00082 | 0.264 |
CLV_PCSK_SKI1_1 | 177 | 181 | PF00082 | 0.221 |
CLV_PCSK_SKI1_1 | 24 | 28 | PF00082 | 0.150 |
CLV_PCSK_SKI1_1 | 354 | 358 | PF00082 | 0.363 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.531 |
DOC_CKS1_1 | 47 | 52 | PF01111 | 0.299 |
DOC_CKS1_1 | 98 | 103 | PF01111 | 0.474 |
DOC_CYCLIN_yCln2_LP_2 | 113 | 119 | PF00134 | 0.281 |
DOC_CYCLIN_yCln2_LP_2 | 47 | 53 | PF00134 | 0.345 |
DOC_MAPK_gen_1 | 177 | 186 | PF00069 | 0.446 |
DOC_MAPK_MEF2A_6 | 45 | 54 | PF00069 | 0.266 |
DOC_MAPK_MEF2A_6 | 63 | 72 | PF00069 | 0.301 |
DOC_PP1_RVXF_1 | 130 | 137 | PF00149 | 0.263 |
DOC_PP1_RVXF_1 | 175 | 182 | PF00149 | 0.445 |
DOC_PP1_RVXF_1 | 352 | 359 | PF00149 | 0.532 |
DOC_PP2B_LxvP_1 | 113 | 116 | PF13499 | 0.281 |
DOC_PP4_FxxP_1 | 98 | 101 | PF00568 | 0.486 |
DOC_USP7_MATH_1 | 305 | 309 | PF00917 | 0.537 |
DOC_WW_Pin1_4 | 46 | 51 | PF00397 | 0.299 |
DOC_WW_Pin1_4 | 97 | 102 | PF00397 | 0.474 |
LIG_14-3-3_CanoR_1 | 150 | 156 | PF00244 | 0.254 |
LIG_14-3-3_CanoR_1 | 290 | 295 | PF00244 | 0.538 |
LIG_Actin_WH2_2 | 159 | 174 | PF00022 | 0.402 |
LIG_AP2alpha_2 | 41 | 43 | PF02296 | 0.446 |
LIG_BRCT_BRCA1_1 | 229 | 233 | PF00533 | 0.470 |
LIG_FHA_1 | 161 | 167 | PF00498 | 0.264 |
LIG_FHA_1 | 47 | 53 | PF00498 | 0.271 |
LIG_FHA_1 | 67 | 73 | PF00498 | 0.306 |
LIG_FHA_1 | 91 | 97 | PF00498 | 0.426 |
LIG_FHA_2 | 143 | 149 | PF00498 | 0.232 |
LIG_FHA_2 | 295 | 301 | PF00498 | 0.436 |
LIG_FXI_DFP_1 | 263 | 267 | PF00024 | 0.211 |
LIG_KLC1_Yacidic_2 | 283 | 287 | PF13176 | 0.548 |
LIG_LIR_Apic_2 | 243 | 249 | PF02991 | 0.421 |
LIG_LIR_Gen_1 | 100 | 111 | PF02991 | 0.426 |
LIG_LIR_Gen_1 | 163 | 171 | PF02991 | 0.264 |
LIG_LIR_Gen_1 | 178 | 189 | PF02991 | 0.469 |
LIG_LIR_Gen_1 | 297 | 307 | PF02991 | 0.562 |
LIG_LIR_Gen_1 | 49 | 58 | PF02991 | 0.291 |
LIG_LIR_Gen_1 | 84 | 92 | PF02991 | 0.317 |
LIG_LIR_Nem_3 | 100 | 106 | PF02991 | 0.438 |
LIG_LIR_Nem_3 | 163 | 167 | PF02991 | 0.257 |
LIG_LIR_Nem_3 | 178 | 184 | PF02991 | 0.421 |
LIG_LIR_Nem_3 | 219 | 224 | PF02991 | 0.330 |
LIG_LIR_Nem_3 | 242 | 247 | PF02991 | 0.418 |
LIG_LIR_Nem_3 | 265 | 269 | PF02991 | 0.419 |
LIG_LIR_Nem_3 | 283 | 288 | PF02991 | 0.440 |
LIG_LIR_Nem_3 | 297 | 302 | PF02991 | 0.475 |
LIG_LIR_Nem_3 | 41 | 46 | PF02991 | 0.450 |
LIG_LIR_Nem_3 | 49 | 54 | PF02991 | 0.266 |
LIG_LIR_Nem_3 | 64 | 70 | PF02991 | 0.181 |
LIG_LIR_Nem_3 | 84 | 89 | PF02991 | 0.434 |
LIG_NRBOX | 208 | 214 | PF00104 | 0.392 |
LIG_Pex14_1 | 206 | 210 | PF04695 | 0.269 |
LIG_Pex14_1 | 255 | 259 | PF04695 | 0.465 |
LIG_Pex14_2 | 160 | 164 | PF04695 | 0.260 |
LIG_Pex14_2 | 202 | 206 | PF04695 | 0.359 |
LIG_PTB_Apo_2 | 101 | 108 | PF02174 | 0.446 |
LIG_PTB_Apo_2 | 253 | 260 | PF02174 | 0.518 |
LIG_PTB_Phospho_1 | 101 | 107 | PF10480 | 0.463 |
LIG_PTB_Phospho_1 | 253 | 259 | PF10480 | 0.518 |
LIG_SH2_CRK | 247 | 251 | PF00017 | 0.411 |
LIG_SH2_PTP2 | 285 | 288 | PF00017 | 0.549 |
LIG_SH2_STAP1 | 107 | 111 | PF00017 | 0.291 |
LIG_SH2_STAP1 | 119 | 123 | PF00017 | 0.257 |
LIG_SH2_STAT3 | 189 | 192 | PF00017 | 0.308 |
LIG_SH2_STAT5 | 133 | 136 | PF00017 | 0.225 |
LIG_SH2_STAT5 | 151 | 154 | PF00017 | 0.221 |
LIG_SH2_STAT5 | 17 | 20 | PF00017 | 0.371 |
LIG_SH2_STAT5 | 189 | 192 | PF00017 | 0.291 |
LIG_SH2_STAT5 | 201 | 204 | PF00017 | 0.242 |
LIG_SH2_STAT5 | 210 | 213 | PF00017 | 0.254 |
LIG_SH2_STAT5 | 285 | 288 | PF00017 | 0.546 |
LIG_SH2_STAT5 | 46 | 49 | PF00017 | 0.335 |
LIG_SH2_STAT5 | 57 | 60 | PF00017 | 0.278 |
LIG_SH2_STAT5 | 75 | 78 | PF00017 | 0.113 |
LIG_SH3_3 | 112 | 118 | PF00018 | 0.280 |
LIG_SH3_3 | 264 | 270 | PF00018 | 0.421 |
LIG_SUMO_SIM_anti_2 | 69 | 74 | PF11976 | 0.341 |
LIG_TRFH_1 | 169 | 173 | PF08558 | 0.311 |
LIG_TRFH_1 | 301 | 305 | PF08558 | 0.547 |
LIG_TYR_ITIM | 208 | 213 | PF00017 | 0.324 |
LIG_WRC_WIRS_1 | 161 | 166 | PF05994 | 0.264 |
LIG_WRC_WIRS_1 | 213 | 218 | PF05994 | 0.392 |
MOD_CK1_1 | 308 | 314 | PF00069 | 0.534 |
MOD_CK2_1 | 10 | 16 | PF00069 | 0.369 |
MOD_CK2_1 | 142 | 148 | PF00069 | 0.232 |
MOD_CMANNOS | 203 | 206 | PF00535 | 0.341 |
MOD_CMANNOS | 252 | 255 | PF00535 | 0.254 |
MOD_GlcNHglycan | 318 | 321 | PF01048 | 0.366 |
MOD_GlcNHglycan | 4 | 7 | PF01048 | 0.213 |
MOD_GSK3_1 | 138 | 145 | PF00069 | 0.248 |
MOD_GSK3_1 | 171 | 178 | PF00069 | 0.518 |
MOD_GSK3_1 | 212 | 219 | PF00069 | 0.330 |
MOD_GSK3_1 | 290 | 297 | PF00069 | 0.442 |
MOD_GSK3_1 | 77 | 84 | PF00069 | 0.271 |
MOD_N-GLC_1 | 305 | 310 | PF02516 | 0.334 |
MOD_NEK2_1 | 122 | 127 | PF00069 | 0.275 |
MOD_NEK2_1 | 160 | 165 | PF00069 | 0.300 |
MOD_NEK2_1 | 2 | 7 | PF00069 | 0.421 |
MOD_NEK2_1 | 212 | 217 | PF00069 | 0.281 |
MOD_NEK2_1 | 233 | 238 | PF00069 | 0.500 |
MOD_NEK2_1 | 288 | 293 | PF00069 | 0.557 |
MOD_PKA_2 | 171 | 177 | PF00069 | 0.446 |
MOD_PKA_2 | 316 | 322 | PF00069 | 0.505 |
MOD_Plk_1 | 305 | 311 | PF00069 | 0.488 |
MOD_Plk_4 | 171 | 177 | PF00069 | 0.465 |
MOD_Plk_4 | 212 | 218 | PF00069 | 0.300 |
MOD_Plk_4 | 294 | 300 | PF00069 | 0.449 |
MOD_Plk_4 | 66 | 72 | PF00069 | 0.247 |
MOD_ProDKin_1 | 46 | 52 | PF00069 | 0.299 |
MOD_ProDKin_1 | 97 | 103 | PF00069 | 0.474 |
MOD_SUMO_for_1 | 179 | 182 | PF00179 | 0.518 |
TRG_DiLeu_BaLyEn_6 | 204 | 209 | PF01217 | 0.324 |
TRG_ENDOCYTIC_2 | 103 | 106 | PF00928 | 0.465 |
TRG_ENDOCYTIC_2 | 107 | 110 | PF00928 | 0.321 |
TRG_ENDOCYTIC_2 | 119 | 122 | PF00928 | 0.286 |
TRG_ENDOCYTIC_2 | 210 | 213 | PF00928 | 0.347 |
TRG_ENDOCYTIC_2 | 247 | 250 | PF00928 | 0.412 |
TRG_ENDOCYTIC_2 | 285 | 288 | PF00928 | 0.443 |
TRG_Pf-PMV_PEXEL_1 | 132 | 137 | PF00026 | 0.463 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P225 | Leptomonas seymouri | 84% | 100% |
A0A0S4IWE2 | Bodo saltans | 51% | 100% |
A0A0S4IZS1 | Bodo saltans | 49% | 100% |
A0A1X0NG21 | Trypanosomatidae | 69% | 100% |
A0A1X0P7H0 | Trypanosomatidae | 69% | 100% |
A0A3S5H7G4 | Leishmania donovani | 99% | 100% |
A0A3S7WZX6 | Leishmania donovani | 99% | 100% |
A4HD58 | Leishmania braziliensis | 84% | 100% |
C4R613 | Komagataella phaffii (strain GS115 / ATCC 20864) | 40% | 100% |
C9ZQX1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 55% | 100% |
E8NHH2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
E9AYE9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
G5EC63 | Caenorhabditis elegans | 40% | 100% |
O09005 | Mus musculus | 41% | 100% |
O15121 | Homo sapiens | 43% | 100% |
O44186 | Caenorhabditis elegans | 40% | 100% |
O59715 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 45% | 100% |
Q0II71 | Bos taurus | 43% | 100% |
Q3ZBY7 | Bos taurus | 42% | 100% |
Q4Q923 | Leishmania major | 96% | 100% |
Q4Q925 | Leishmania major | 98% | 100% |
Q564G3 | Rattus norvegicus | 41% | 100% |
Q5AJX2 | Candida albicans (strain SC5314 / ATCC MYA-2876) | 44% | 98% |
Q5F3C1 | Gallus gallus | 40% | 100% |
Q5RE51 | Pongo abelii | 42% | 100% |
Q5XIF5 | Rattus norvegicus | 42% | 100% |
Q68FB8 | Xenopus tropicalis | 42% | 100% |
Q6H5U3 | Oryza sativa subsp. japonica | 44% | 100% |
Q6QHC5 | Homo sapiens | 43% | 100% |
Q6UQ04 | Microtus fortis | 41% | 100% |
Q8R2F2 | Mus musculus | 41% | 100% |
Q94515 | Drosophila melanogaster | 43% | 100% |
Q9ZPH4 | Arabidopsis thaliana | 42% | 100% |
V5DBA3 | Trypanosoma cruzi | 66% | 100% |